retatrutide trial status safety approval: FDA status, clinical results, and when it could be available Triple hormone receptor agonist retatrutide – Retatrutide Severe Obesity Trial Shows

Zepbound, a newer option, targets appetite and glucose control, while Semaglutide is well-known for its strong impact on weight loss

Counterfeit Botox that sickened people across the country in April 2024 (FDA) An August 2025 expos in Elle about bad actors and loose regulation in the medical spa industry included the story of a Boston woman who falsely claimed to be a registered nurse and injected patients with counterfeit products from Brazil and China

Follow us on Google and Google News.

26 percent had diabetes and 45 percent had obesity

For a common lateral sprain (ATFL), the injection would be on the outer side of the ankle

2018 Nov;203:52-53